Page
%P
-
Article
Open AccessGlucose–insulin–potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials
Glucose-insulin-potassium (GIK) has been advocated in the setting of acute coronary syndrome (ACS) to reduce ischemia-related arrhythmias and myocardial injury. We conducted a meta-analysis of randomized contr...